Understanding and modifying gut bacteria for better health
Combining chemical and computational tools for predictive models of microbiome communities
This study is exploring how the bacteria in our gut affect health issues like obesity and diabetes, and it's for anyone interested in new ways to improve gut health through special tools that can change and monitor these bacteria.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10909224 on NIH RePORTER |
What this research studies
This research focuses on the gut microbiome, which plays a crucial role in various health conditions like obesity, diabetes, and cardiovascular diseases. The team aims to develop new tools to precisely modify the bacteria in the gut, allowing for better understanding and treatment of microbiome-related diseases. They will create molecular tools to target specific bacteria, analyze how these communities interact, and design an ingestible biosensor for real-time monitoring of gut bacteria. This innovative approach could lead to novel therapies that improve patient health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from obesity, diabetes, inflammatory bowel disease, cardiovascular diseases, or other conditions influenced by the gut microbiome.
Not a fit: Patients with conditions unrelated to the gut microbiome or those who do not have access to the necessary monitoring tools may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted therapies that improve health by modifying gut bacteria.
How similar studies have performed: Previous research has shown promise in modifying gut microbiota for health benefits, indicating that this approach could yield significant advancements.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: De la Fuente, Cesar — University of Pennsylvania
- Study coordinator: De la Fuente, Cesar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.